Drug Profile
UK 396082
Alternative Names: TAFI inhibitor; UK-396,082Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Pfizer
- Class Amino acids; Antithrombotics; Imidazoles
- Mechanism of Action Carboxypeptidase U inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pulmonary fibrosis; Thrombosis
Most Recent Events
- 31 Mar 2010 Phase-I clinical trials in Thrombosis in Belgium (PO)
- 07 Apr 2006 Phase-I clinical trials in Thrombosis in United Kingdom (PO)